Paper Details

  1. Home
  2. Paper Details

Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.

Author: AttarMayssa, BejanianMarina, BurkeJames, CooteMichael, RobinsonMichael R, SealJennifer R

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the ocular distribution of bimatoprost, a drug used to lower eye pressure, when delivered via a sustained-release implant versus repeated topical applications in dogs. The study aimed to assess the potential differences in drug delivery and distribution between these two methods.
Paper Details　
Original Abstract of the Article :
To explore the ocular distribution of bimatoprost after intracameral administration of a biodegradable sustained-release bimatoprost implant (Bimatoprost SR) versus repeated topical administration of bimatoprost 0.03% ophthalmic solution in dogs. Bimatoprost SR and topical bimatoprost 0.03% previous...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354606/

データ提供：米国国立医学図書館（NLM）

Bimatoprost Delivery: A Targeted Approach to Glaucoma

Glaucoma, a condition that can lead to vision loss, is like a sandstorm slowly eroding the landscape of our vision. This study investigates the ocular distribution of bimatoprost, a medication used to lower intraocular pressure, after administration via a sustained-release implant compared to topical application. The authors use a canine model, like studying the behavior of camels in their natural environment, to gain insights into the drug's distribution within the eye.

Delivering Bimatoprost: A Controlled Release

The study found that the sustained-release implant effectively delivered bimatoprost to the target tissues in the eye, while minimizing exposure to off-target tissues. This is like using a water-carrying camel to deliver precious water resources to specific areas in the desert, ensuring optimal hydration and minimizing waste. The authors conclude that the sustained-release implant provides a more targeted approach to bimatoprost delivery, potentially offering advantages over traditional topical administration.

Protecting Our Vision: A Desert Oasis for Glaucoma Patients

This research has the potential to improve the management of glaucoma by optimizing the delivery of bimatoprost, a crucial medication for lowering intraocular pressure. By delivering the drug more effectively to the target tissues, we can potentially minimize side effects and improve treatment outcomes. This is like finding a desert oasis that provides both sustenance and protection from the harsh desert elements, leading to improved vision and overall well-being.

Dr.Camel's Conclusion

This study highlights the potential benefits of using a sustained-release implant to deliver bimatoprost for the treatment of glaucoma. This approach could provide a more targeted and efficient way to deliver the medication, potentially leading to improved outcomes for patients.

Date :
  1. Date Completed 2020-07-06
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

30335560

DOI: Digital Object Identifier

PMC6354606

Related Literature

Article Analysis
・Side Effects of bimatoprost topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.